Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses. | Comput Intell Neurosci | 2022 | 35528328 | PubTator, text mining | PubMed |
| Does the "Tian-Ren-He-Yi" Belief System Promote Corporate Environmental Performance? | Front Psychol | 2022 | 35519634 | PubTator, text mining | PubMed |
| Danggui Buxue Decoction Ameliorates Idiopathic Pulmonary Fibrosis through MicroRNA and Messenger RNA Regulatory Network. | Evid Based Complement Alternat Med | 2022 | 35518349 | PubTator, text mining | PubMed |
| Broad-range metalloprotease profiling in plants uncovers immunity provided by defence-related metalloenzyme. | New Phytol | 2022 | 35510806 | PubTator, text mining | PubMed |
| The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside. | J Ginseng Res | 2022 | 35509820 | PubTator, text mining | PubMed |
| Walking a tightrope: The complex balancing act of R-loops in genome stability. | Mol Cell | 2022 | 35508167 | PubTator, text mining | PubMed |
| Publisher Correction: Signatures of TOP1 transcription-associated mutagenesis in cancer and germline. | Nature | 2022 | 35504971 | PubTator, text mining | PubMed |
| Somatic Alteration Characteristics of Early-Onset Gastric Cancer. | J Oncol | 2022 | 35498538 | PubTator, text mining | PubMed |
| Clinical risk scores for stroke correlate with molecular signatures of vulnerability in symptomatic carotid patients. | iScience | 2022 | 35494231 | PubTator, text mining | PubMed |
| Ubiquitin-directed AAA+ ATPase p97/VCP unfolds stable proteins crosslinked to DNA for proteolysis by SPRTN. | J Biol Chem | 2022 | 35469923 | PubTator, text mining | PubMed |
Design and synthesis of novel 7-ethyl-10-fluoro-20-O-(cinnamic acid ester)-camptothecin derivatives as potential high selectivity and low toxicity topoisomerase I inhibitors for hepatocellular carcinoma. | Biochem Pharmacol | 2022 | 35469784 | PubTator, text mining | PubMed |
| Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme. | Front Immunol | 2022 | 35464443 | PubTator, text mining | PubMed |
| SUMO: A Swiss Army Knife for Eukaryotic Topoisomerases. | Front Mol Biosci | 2022 | 35463961 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment. | Front Oncol | 2022 | 35463320 | PubTator, text mining | PubMed |
Diagnosis of Chronic Obstructive Pulmonary Disease and Regulatory Mechanism of miR-149-3p on Alveolar Inflammatory Factors and Expression of Surfactant Proteins A (SP-A) and D (SP-D) on Lung Surface Mediated by Wnt Pathway. | Comput Intell Neurosci | 2022 | 35463266 | PubTator, text mining | PubMed |
| Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR). | Molecules | 2022 | 35458687 | PubTator, text mining | PubMed |
In Vitro and In Silico Studies of Human Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) Inhibition by Stereoisomeric Forms of Lipophilic Nucleosides: The Role of Carbohydrate Stereochemistry in Ligand-Enzyme Interactions. | Molecules | 2022 | 35458631 | PubTator, text mining | PubMed |
| Dual-Functional Polymeric Micelles Co-Loaded with Antineoplastic Drugs and Tyrosine Kinase Inhibitor for Combination Therapy in Colorectal Cancer. | Pharmaceutics | 2022 | 35456602 | PubTator, text mining | PubMed |
| Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action. | Cells | 2022 | 35456005 | PubTator, text mining | PubMed |
| Special Issue "Anticancer Drugs 2021". | Pharmaceuticals (Basel) | 2022 | 35455476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=53